DGIFD Digital Info Security

D7 Health Products Not Impacted by Coronavirus - COVID-19

Arvada, Colorado--(Newsfile Corp. - March 3, 2020) - D7 Enterprises, Inc. (OTC Pink: DGIF) today announced the Coronavirus is not impacting D7's sales or production. In light of the public market performance reportedly in reaction to Coronavirus concerns, D7's management believed it worthwhile to emphasize that the Coronavirus has had no impact on D7 Enterprises operations nor its product delivery schedules.

In spite of the recent market performance reportedly in reaction to the Coronavirus, D7 is proud to announce that its new D7 Health Products division will be the focus of D7's therapeutic CBD/CBG consumer products. , and the new division is currently developing a complete line of products to meet that demand. The products will be sold under the D7 brand name and the company will be setting up a direct sales portal that will be announced soon.

The move is the first in an anticipated series of acquisitions or expansions for the company. The vision of the company is to build a 100% vertically integrated supplier for hemp products. Thus far, the company has developed its growing and cultivation relationships with farmers and is securing the best genetics that the industry can provide. It has secured secure processing and extraction through strategic partnerships and expects to have news on future enhancements in that area soon.

The company is currently working to build a pipeline of more acquisition opportunities.

ABOUT D7 Enterprises, Inc. (OTC Pink: DGIF) is a Colorado based company with divisions in Hemp related products and Digital Services. It has aligned itself with industry leaders in both industries and has products that it is selling directly to consumers and through distribution channels. It intends to build a 100% vertically integrated Hemp products division that will control the genetics of its product and maintain the highest quality throughout the cycle of use.

For question or comments please contact James Clark at 720-427-8938 or visit our webpage at

SAFE HARBOR STATEMENT Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently, and other factors detailed in reports filed by the Company.

To view the source version of this press release, please visit

EN
03/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Digital Info Security

 PRESS RELEASE

D7 Health Products Not Impacted by Coronavirus - COVID-19

Arvada, Colorado--(Newsfile Corp. - March 3, 2020) - D7 Enterprises, Inc. (OTC Pink: DGIF) today announced the Coronavirus is not impacting D7's sales or production. In light of the public market performance reportedly in reaction to Coronavirus concerns, D7's management believed it worthwhile to emphasize that the Coronavirus has had no impact on D7 Enterprises operations nor its product delivery schedules.In spite of the recent market performance reportedly in reaction to the Coronavirus, D7 is proud to announce that its new D7 Health Products division will be the focus of D7's therapeutic ...

 PRESS RELEASE

D7 Enterprises Expands Into Highly Lucrative Hemp Business Market

Arvada, Colorado--(Newsfile Corp. - March 2, 2020) - D7 Enterprises, Inc. (OTC Pink: DGIF) is happy to announce that it is expanding its business by entering the rapidly growing Therapeutic and Industrial Hemp industry. , all part of the overall . In 2019 the company raised a high-quality seed crop that yielded over 1 million seeds. This variety of hemp is high in CBD, 10-16%, These seeds are worth over $1 per seed and is currently in inventory. and will be the launch into the highly lucrative market. Our focus is to only produce the legalized HEMP, and not anything to do with THC or mar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch